Valuation: IDEXX Laboratories, Inc.

Capitalization 41.81B 36.29B 34.18B 31.09B 57.41B 3,619B 64.82B 403B 155B 1,657B 157B 154B 6,106B P/E ratio 2025 *
42.7x
P/E ratio 2026 * 38.1x
Enterprise value 42.93B 37.27B 35.1B 31.93B 58.95B 3,716B 66.55B 414B 159B 1,702B 161B 158B 6,270B EV / Sales 2025 *
10.4x
EV / Sales 2026 * 9.53x
Free-Float
75.42%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.78%
1 week-0.57%
Current month+2.06%
1 month+0.43%
3 months+24.11%
6 months+28.09%
Current year+26.72%
More quotes
1 week 513.92
Extreme 513.9185
530.12
1 month 496.61
Extreme 496.61
530.73
Current year 356.14
Extreme 356.14
530.73
1 year 356.14
Extreme 356.14
530.73
3 years 317.06
Extreme 317.06
583.39
5 years 311.48
Extreme 311.485
706.95
10 years 61.58
Extreme 61.58
706.95
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 27/06/2019
Chief Operating Officer 57 31/12/2024
Chief Tech/Sci/R&D Officer 57 14/01/2020
Director TitleAgeSince
Director/Board Member 74 15/07/2012
Director/Board Member 64 22/10/2019
Director/Board Member 63 14/07/2013
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.78%-0.57%+4.03%+59.71% 41.81B
Average +0.78%-0.81%+4.03%+59.71% 41.81B
Weighted average by Cap. +0.78%-0.81%+4.03%+59.71%
See all sector performances

Financials

2025 *2026 *
Net sales 4.14B 3.59B 3.38B 3.08B 5.68B 358B 6.41B 39.93B 15.31B 164B 15.52B 15.19B 604B 4.46B 3.87B 3.64B 3.31B 6.12B 386B 6.91B 43.01B 16.49B 177B 16.72B 16.36B 651B
Net income 985M 855M 805M 732M 1.35B 85.23B 1.53B 9.5B 3.64B 39.04B 3.69B 3.62B 144B 1.09B 948M 893M 812M 1.5B 94.55B 1.69B 10.54B 4.04B 43.31B 4.1B 4.01B 160B
Net Debt 1.12B 972M 916M 833M 1.54B 96.96B 1.74B 10.81B 4.15B 44.41B 4.2B 4.11B 164B 660M 573M 540M 491M 907M 57.14B 1.02B 6.37B 2.44B 26.17B 2.48B 2.42B 96.41B
More financial data * Estimated data
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
More about the company
Date Price Change Volume
20/06/25 523.92 $ +0.78% 1,052,193
18/06/25 519.85 $ -0.14% 590,939
17/06/25 520.59 $ -1.55% 430,708
16/06/25 528.77 $ +1.16% 371,840
13/06/25 522.70 $ -0.80% 411,465

Delayed Quote Nasdaq, June 20, 2025 at 09:00 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
519.85USD
Average target price
507.08USD
Spread / Average Target
-2.46%
Consensus

Quarterly revenue - Rate of surprise